Delayed Ocrevus Infusion May Increase RRMS Risk & A Bump on the BTK Inhibitor Road

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting that an interval dosing of Ocrevus of one month or longer was linked to a fivefold higher risk of MRI-based disease activity.
He also reads “Researchers Hit a Bump on the BTK Inhibitor Road” by Ed Tobias, from his column "The MS Wire".
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/